Two people in Denmark suffered brain haemorrhages after receiving AstraZeneca’s COVID-19 vaccine, according to several reports.
Two hospital staff members received the vaccine less than 14 days before experiencing a brain haemorrhage. Reuters reported. The Danish Medicines Agency confirmed that it had received two “serious reports”, but did not provide further details.
The New York Times reported that one of the patients had died, and the other one, a woman in her thirties, was critically ill.
The Hill released AstraZeneca for comment.
The reports are the latest amid a series of media reports about a small number of people getting blood clots after shots of AstraZeneca’s vaccine. The news also represents the second death in Denmark following the administration of the vaccine by the British-Swedish company.
Denmark discontinued use of the vaccine on March 11 after a 60-year-old woman died from the blood clot following the shot. Other countries, including Germany, France, Italy, Spain, Ireland and Norway, have also blocked its use.
The vaccine has yet to be approved by the U.S. Food and Drug Administration.
AstraZeneca said last Sunday that there was no evidence linking the vaccine to blood clots after 17 million were reviewed shots fired across Europe.
The European Medicines Agency, the European Union’s Drug Regulator, Said Thursday that the AstraZeneca vaccine is safe and effective to use, but that it is not associated with blood clots. The agency said it would add a warning to the product about the possibility of the side effect.
Reuters noted that some countries have reversed their decisions amid the EMA announcement.
The World Health Organization has recommended that countries continue to use the vaccine and say that the benefits of the vaccine outweigh its risks.